IMDX

Insight Molecular Diagnostics

IMDX

Market cap $165M

5.10 USD

+0.12

2.41%

At close Updated May 13, 4:00 PM EDT

Pre-market

After hours

4.90

-0.20

3.92%

1 day

2.41%

5 days

1.8%

1 month

70%

3 months

-8.44%

6 months

-35.03%

Year to date

-28.77%

1 year

84.12%

5 years

-93.34%

10 years

-93.66%

About: Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.

Employees: 58

Healthcare Diagnostics & Research